FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
|Articles|December 2, 2009
Reader Feedback About "Cholesterol Mnemonic Aids Patient Education"
In response to the Practical Pointer "Cholesterol Mnemonic Aids Patient Education" (CONSULTANT, August 2008) about patients who have difficulty remembering the difference between HDL and LDL cholesterol, I use "H" is for happy and "L" is for lousy!
Advertisement
In response to the Practical Pointer
-Sylvie Rosenbloom, MSN, BC-FNP
Scarsdale, NY
Advertisement
Related to this article
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
2
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
Clinical Inertia and Poor Measurement Technique Undermine BP Control
5